Author

S. Gallinger

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1

Frequent Co-Authors

G. H. Jang· 3 shared B. T. Grünwald· 2 shared F. Notta· 2 shared F. Vyas· 2 shared K. Aliar· 2 shared P. Bronsert· 2 shared R. Khokha· 2 shared S. E. Fischer· 2 shared

Activity by Year

2021-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

G. H. Jang

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

MICAL2 Is a Super Enhancer Associated Gene that Promotes Pancreatic Cancer Growth and Metastasis

B. Garg, S. Khan, D. Sheikh Babu, E. Mose, K. Gulay, S. Sharma, D. Sood, A. T. Wenzel, A. Martsinkovskiy, J. Patel, D. Jaquish, G. Lambies, A. D Ippolito, K. Austgen, B. Johnston, , A. M. Lowy

This study identifies MICAL2 as a super enhancer-associated gene that promotes pancreatic cancer growth and metastasis through multiple molecular mechanisms.

bioRxiv · Jun 26, 2024 · PreprintCancer Biology

Hourglass, a tool to mine bioimaging data, uncovers sex-disparities in the IL-6-associated T cell response in pancreatic tumors

K. Aliar, H. R. Waterhouse, F. Vyas, N. Krebs, E. Poulton, B. Zhang, N. Chan, P. Bronsert, S. E. Fischer, S. Gallinger, B. T. Grünwald, R. Khokha

Hourglass processes bioimaging data to reveal sex-specific IL-6 effects on T cell responses in pancreatic tumors.

bioRxiv · Sep 12, 2022 · PreprintCancer Biology

In vivo CRISPR screens reveal SCAF1 and USP15 as novel drivers of pancreatic cancer

S. Martinez, R. Weber, T. Woo, A. Malik, M. Geuenich, G. H. Jang, D. Dervovic, K. Al-Zahrani, R. Tsai, N. Fodil, P. Gros, S. S. Sidhu, S. Gallinger, G. Neely, K. Campbell, , D. Schramek

This study uses in vivo CRISPR screens to identify USP15 and SCAF1 as novel tumor suppressors in pancreatic cancer, with potential therapeutic implications.

bioRxiv · Mar 13, 2022Cancer Biology

Spatially confined sub-tumor microenvironments orchestrate pancreatic cancer pathobiology

B. T. Grünwald, A. Devisme, G. Andrieux, F. Vyas, K. Aliar, C. W. McCloskey, A. Macklin, G. H. Jang, R. Denroche, J. M. Romero, P. Bavi, P. Bronsert, F. Notta, G. O'Kane, J. Wilson, , R. Khokha

This study identifies spatially confined sub-tumor microenvironments in PDAC that drive distinct tumor progression outcomes.

bioRxiv · Feb 18, 2021Cancer Biology